James V. Cassella
2019
In 2019, James V. Cassella earned a total compensation of $1.7M as Chief Development Officer at Concert Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $217,697 |
|---|---|
| Option Awards | $708,563 |
| Salary | $435,394 |
| Stock Awards | $319,397 |
| Other | $13,988 |
| Total | $1,695,039 |
Cassella received $708.6K in option awards, accounting for 42% of the total pay in 2019.
Cassella also received $217.7K in non-equity incentive plan, $435.4K in salary, $319.4K in stock awards and $14K in other compensation.
Rankings
In 2019, James V. Cassella's compensation ranked 6,726th out of 13,971 executives tracked by ExecPay. In other words, Cassella earned more than 51.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,726 out of 13,971 | 52nd |
Division Manufacturing | 2,562 out of 5,701 | 55th |
Major group Chemicals And Allied Products | 936 out of 2,200 | 58th |
Industry group Drugs | 791 out of 1,886 | 58th |
Industry Pharmaceutical Preparations | 578 out of 1,398 | 59th |
Source: SEC filing on April 28, 2020.
Cassella's colleagues
We found two more compensation records of executives who worked with James V. Cassella at Concert Pharmaceuticals in 2019.